Literature DB >> 6648594

Visual disability and blindness secondary to refractive errors in Africa.

L Schwab, P G Steinkuller.   

Abstract

Optical defects of the light-focusing apparatus of the eye are called errors of refraction. They are responsible for 13% of all significant vision loss in Kenya, ranking third of all causes, after cataract and trachoma. As the overall prevalence of such visual impairment in the Country is 3.7%, roughly 0.5% of the population can be said to need spectacles to obtain normal vision. The comparable figure for secondary school children in Nigeria has been found to be 2.4%. In addition, patients require special spectacles after cataract surgery to obtain adequate vision; without such spectacles these patients are still 'blind' by World Health Organization criteria. These glasses can be obtained through mission societies and various charitable organizations for a little as $5 per pair, and can be manufactured locally with available ophthalmic manpower and technology. Alternatives to spectacles such as contact lenses, intra-ocular lenses and Kerato-refractive surgery are not suitable for use in developing Countries.

Entities:  

Mesh:

Year:  1983        PMID: 6648594     DOI: 10.1016/0277-9536(83)90387-8

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  3 in total

1.  Seven-year incidence of uncorrected refractive error among an elderly Chinese population in Shihpai, Taiwan: The Shihpai Eye Study.

Authors:  T-M Kuang; S-Y Tsai; C J-L Liu; Y-C Ko; S-M Lee; P Chou
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

2.  Primary eye care in rural sub-Saharan Africa.

Authors:  P G Steinkuller
Journal:  Int Ophthalmol       Date:  1987-12       Impact factor: 2.031

3.  Blindness and visual impairment in southern Malawi.

Authors:  M C Chirambo; J M Tielsch; K P West; J Katz; T Tizazu; L Schwab; G Johnson; J Swartwood; H R Taylor; A Sommer
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.